No Data
No Data
Express News | BioXcel Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results
BioXcel Therapeutics, Inc. (BTAI) Q1 2024 Earnings Call Transcript
BioXcel Therapeutics, Inc. (BTAI) Q1 2024 Earnings Call Transcript
BioXcel Therapeutics | 10-Q: Quarterly report
BioXcel Therapeutics Q1 2024 GAAP EPS $(0.87) Beats $(1.04) Estimate, Sales $582.000K Beat $464.000K Estimate
BioXcel Therapeutics (NASDAQ:BTAI) reported quarterly losses of $(0.87) per share which beat the analyst consensus estimate of $(1.04) by 16.35 percent. This is a 52.72 percent increase over losses of
Express News | BioXcel Therapeutics Reports First Quarter 2024 Financial Results
Express News | BioXcel Therapeutics Q1 Net Income USD -26.791 Million Vs. Ibes Estimate USD -23.2 Million